日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

American College of Rheumatology Guidance Statement for Diagnosis and Management of VEXAS Developed by the International VEXAS Working Group Expert Panel

美国风湿病学会关于VEXAS诊断和治疗的指导声明,由国际VEXAS工作组专家组制定

Mekinian, Arsene; Georgin-Lavialle, Sophie; Ferrada, Marcela A; Savic, Sinisa; Koster, Matthew J; Kosmider, Olivier; Comont, Thibault; Heiblig, Mael; Arostegui, Juan I; Bosco, Annmarie; Bourguiba, Rim; Calvo, Katherine R; Cargo, Catherine; Cattaneo, Chiara; Chasset, François; Coelho, Henrique; Campochiaro, Corrado; Crisafulli, Francesca; Ducharme-Benard, Stephanie; Faria, Raquel; Franceschini, Franco; Frassi, Micol; Groarke, Emma M; Gurnari, Carmelo; Hakobyan, Yervand; Jamilloux, Yvan; Jurcut, Ciprian; Kirino, Yohei; Kulasekararaj, Austin; Kunimoto, Hiroyoshi; Madigan, Lauren M; Mann, Heřman F; Marvisi, Chiara; Milchert, Marcin; Morais, Sara; Sockel, Katja; Muratore, Francesco; Nakajima, Hideaki; Patnaik, Mrinal M; Regadas, Luísa; Robin, Marie; Rutgers, Abraham; Salvarani, Carlo; Sammel, Anthony M; Seebach, Joerg; Sujobert, Pierre; Tomelleri, Alessandro; Urbanski, Geoffrey; Vandergheynst, Frédéric; Vieira, Romana; Viswanatha, David S; Więsik-Szewczyk, Ewa; Diral, Elisa; Terrier, Benjamin; Patel, Bhavisha A; Fenaux, Pierre; Grayson, Peter C; Beck, David B

Association Between Patient-Reported Outcomes and Overall Survival in Patients with Advanced NSCLC Treated with First-Line Cemiplimab-Based Therapy

一线塞米普利单抗治疗晚期非小细胞肺癌患者中,患者报告结局与总生存期之间的关联

Gandara, David R; Makharadze, Tamta; Gümüş, Mahmut; Gogishvili, Miranda; Sezer, Ahmet; Kim, Eric; Yan, Eric; Seebach, Frank; Harnett, James; Quek, Ruben G W

First-Line Cemiplimab for Locally Advanced NSCLC: Updated Subgroup Analyses From the EMPOWER-Lung 1 and EMPOWER-Lung 3 Trials

一线 Cemiplimab 治疗局部晚期非小细胞肺癌:EMPOWER-Lung 1 和 EMPOWER-Lung 3 试验的最新亚组分析

Kalinka, Ewa; Bondarenko, Igor; Gogishvili, Miranda; Melkadze, Tamar; Baramidze, Ana; Sezer, Ahmet; Makharadze, Tamta; Kilickap, Saadettin; Gümüş, Mahmut; Penkov, Konstantin; Giorgadze, Davit; Özgüroğlu, Mustafa; Quek, Ruben G W; McIntyre, Debra A G; Kim, Eric; Seebach, Frank; Pouliot, Jean-Francois

Cemiplimab in Japanese patients with advanced non-small cell lung cancer

Cemiplimab 用于治疗日本晚期非小细胞肺癌患者

Sato, Yuki; Tani, Yoko; Ishii, Hidenobu; Katakura, Seigo; Oki, Masahide; Watanabe, Yasutaka; Yokoyama, Toshihide; Naoki, Katsuhiko; Pouliot, Jean-Francois; Kaul, Manika; Paccaly, Anne; Visich, Jennifer E; Kim, Eric; Mani, Jayakumar; Li, Yuntong; Lowy, Israel; Seebach, Frank; Mathias, Melissa; Ikeda, Satoshi

Review of patient-reported outcomes in EMPOWER-Lung 1 in patients with advanced non-small cell lung cancer treated with cemiplimab versus chemotherapy

对 EMPOWER-Lung 1 研究中接受 cemiplimab 治疗与化疗治疗的晚期非小细胞肺癌患者的患者报告结局进行回顾

Gandara, David R; Gümüş, Mahmut; Kilickap, Saadettin; Sezer, Ahmet; Bondarenko, Igor; Özgüroğlu, Mustafa; Gogishvili, Miranda; Yan, Eric; Jia, Xue; Kim, Eric; Seebach, Frank; Quek, Ruben G W

TNF-α induces VE-cadherin-dependent gap/JAIL cycling through an intermediate state essential for neutrophil transmigration

TNF-α诱导VE-钙黏蛋白依赖的间隙/JAIL循环,该循环通过中性粒细胞跨内皮迁移所必需的中间状态进行。

Jan Philip Kipcke ,Maria Odenthal-Schnittler,Mohammed Aldirawi,Jonas Franz ,Vesna Bojovic,Jochen Seebach,Hans Schnittler

Clinical Interchangeability of PD-L1 Immunohistochemistry Assays in First-Line Non-Small Cell Lung Cancer Management With Cemiplimab

PD-L1免疫组化检测在西米普利单抗一线治疗非小细胞肺癌中的临床互换性

Perez, Javier; Kerr, Keith M; Baker, Brian; Fang, Fang; Li, Jason; McDonald, Jannine; Li, Siyu; Gao, Bo; Pouliot, Jean-Francois; Seebach, Frank; Lowy, Israel; Gullo, Giuseppe; Herman, Gary; Hamilton, Jennifer; Rietschel, Petra; McGuire, Kristina

Cemiplimab monotherapy as first-line treatment of patients with brain metastases from advanced non-small cell lung cancer with programmed cell death-ligand 1 ≥50

Cemiplimab 单药治疗作为一线治疗方案,用于治疗程序性死亡配体 1 (PD-L1) ≥50 的晚期非小细胞肺癌脑转移患者。

Kilickap, Saadettin; Özgüroğlu, Mustafa; Sezer, Ahmet; Gümüş, Mahmut; Bondarenko, Igor; Gogishvili, Miranda; Turk, Haci M; Cicin, Irfan; Bentsion, Dmitry; Gladkov, Oleg; Sriuranpong, Virote; Quek, Ruben G W; McIntyre, Debra A G; He, Xuanyao; McGinniss, Jennifer; Seebach, Frank; Gullo, Giuseppe; Rietschel, Petra; Pouliot, Jean-Francois

Protein succinylome analysis identifies citrate synthase as a central regulator of osteoclast metabolic activity.

蛋白质琥珀酰化组分析表明,柠檬酸合酶是破骨细胞代谢活动的核心调节因子

Yu Dayoung, Gao Yue, Luzarowski Marcin, Seebach Elisabeth, Heitkamp Thomas, Börsch Michael, Ruppert Thomas, Kubatzky Katharina F

Dendritic Cells in Xenotransplantation: Shaping the Cellular Immune Response Toward Tolerance

树突状细胞在异种移植中的作用:塑造细胞免疫反应以诱导耐受性

Puga Yung, Gisella L; Wakley, Tom; Kouklas, Athanasios; Seebach, Jörg D